ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIIB Biogen Inc

194.38
3.86 (2.03%)
Apr 19 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Biogen Inc BIIB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
3.86 2.03% 194.38 20:00:00
Open Price Low Price High Price Close Price Prev Close
190.72 189.44 194.525 194.38 190.52
more quote information »

Recent News

Date Time Source Heading
3/31/202419:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
3/06/202407:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
3/04/202416:15GLOBEBiogen Highlights New Data at the International Conference..
2/26/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/23/202407:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
2/22/202410:12EDGAR2Form 144 - Report of proposed sale of securities
2/21/202421:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202421:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202421:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202421:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202421:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202421:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202410:24EDGAR2Form 144 - Report of proposed sale of securities
2/20/202421:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202407:07EDGAR2Form 8-K - Current report
2/12/202419:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202419:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
2/12/202411:10EDGAR2Form 144 - Report of proposed sale of securities
2/09/202420:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202419:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202410:44EDGAR2Form 144 - Report of proposed sale of securities
1/31/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202414:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/19/202307:30GLOBECentralized Marketing Authorizations of Generic Versions of..
12/15/202309:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
12/14/202306:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..

Your Recent History

Delayed Upgrade Clock